DCGI

DCGI Approves Phase II/III Clinical Trial of COVAXIN Among Age Group of 2 to 18 Years

Bharat Biotech International Ltd., Hyderabad (BBIL) had proposed to carry out a Phase- II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers.

By SMEStreet Edit Desk

May 13, 2021 10:36 IST logo

1 Min read

VG Somani, DCGI, Drug controller general of India

News

DGCI Gave Approvals To Serum Institute for Clinical Trials of Oxford COVID-19 Vaccine

By SMEStreet Edit Desk

Sep 16, 2020 04:27 IST logo

2 Min read

News

DCGI Grants Approval for Pneumococcal Polysaccharide Conjugate Vaccine to Serum Institute

By SMEStreet Edit Desk

Jul 15, 2020 11:02 IST logo

1 Min read

Made in India Favipiravir, Biophore, DCGI, SMEStreet

LimeLight

Biophore Claims the Validation for Scaled Up Production of Made-In-India Favipiravir for Covid-19

By SMEStreet Desk

Jul 14, 2020 06:02 IST logo

2 Min read